Business & Industry

It is projected that the market for pharmaceutical contract manufacturing organizations (CMOs) would expand at a compound annual growth rate (CAGR) of 7.29 percent until the year 2028. This rise may be ascribed to the expanded pharmaceutical industry, which...

During the period of time from 2023 to 2029, the global market for cell and gene therapy Contract Development and Manufacturing Organization (CDMO) services is projected to grow at a compound annual growth rate (CAGR) of 17.5%. In 2022,...

Pharmaceutical businesses increasingly outsource their product development and manufacture to Contract Development and manufacture Organizations (CDMOs), which operate in a fragmented sector that is experiencing significant restructuring. However, a lot of CDMOs put their competitiveness at risk by not...

Thermo Fisher to acquire Clario Holdings, the clinical trial data firm, for $8.9 billion in cash is in news and the same has been announced by the companies on October 29. Clario is at present held by a shareholder group...

One of the leading contract development and manufacturing organization – CDMO that specializes in high-quality sterile injectables, Simtra BioPharma Solutions, has made tremendous progress on a dual-continent expansion strategy in order to meet the growing global demand for intricate...

Heads to Chongqing for its 93rd edition API China, Asia’s authoritative exhibition for pharmaceutical ingredients and manufacturing, will convene its 93rd edition at the Chongqing International Expo Center from 12–14 November 2025. Held twice annually, the event is one of the largest gatherings...

Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, announced the promotion of David Stevens, Chief Operating and Commercial Officer, to the newly created role of President. In this capacity, David will lead Kindeva’s global...